Dr. Beth Hartog — Publications

    Selected Publications: Dr. Beth Hartog

    • Riozin-Towle L, Meltzer HL, Hall EJ, Bigalow JC and Hartog B: Hypoxia mediated drugs and chemosensitization. Presented at 24th Annual Scientific Meeting of the American Society of Therapeutic Radiologists. Kissimee, Florida, October 25-29, 1982.
    • Astor, MB, Parham JC, Hall EJ, Templeton MA and Hartog B: A 3-nitro triazole as a hypoxic cell sensitizer. British Journal of Cancer. 47: 155-157, 1983.
    • Astor MB, Hall EJ, Bigalow JC and Hartog B: In Vitro studies with two human cell lines deficient in glutathione. Seventh International Congress of Radiation Research. Amsterdam, The Netherlands, July 3-8, 1983.
    • Riozin-Towle L, Hall EJ, Meltzer HL and Hartog B: Chemosensitization In Vitro. Thirty-Second Annual Meeting of the Radiation Research Society, Orlando, Florida, March 25-29, 1984.
    • Astor MB, Hall EJ, and Hartog B: Thiols and radiosensitivity. Abstracts of Thirty-Second Annual Meeting of the Radiation Research Society. Orlando, Florida, March 25-29, 1984.
    • Cruz J, Dubey A, Hartog B and Gindoff P: Is blastocyst transfer useful as an alternative treatment for IVF patients with previous IVF failure? Abstract P-355, Proceedings of the Annual Meeting of the American Society of Reproductive Medicine, October 1998.
    • Stratton P, Hartog B, Hajizadeh N, Piguion J, Sutherland D, and Nieman LK. Effect of single mid-follicular dose of the CDB 2914, a new anti-progestin, on folliculogenesis. Abstract 0-105, Proceedings of the 54th Annual Meeting of the American Society of Reproductive Medicine. San Francisco, California, October 4-9, 1998.
    • Hartog B, Gindoff P. Opiod Peptides and Reproduction. The Endocrinologist, 8:1, 1998.
    • Dubey AK, Cruz J, Hartog B and Gindoff PR. Serum collected on the day of embryo transfer from patients undergoing IVF shows toxic effect on development of mouse blastocyst. Abstract P-095, Proceedings of the 11th World Congress on IVF and Human Reproductive Genetics. Sydney, Australia, May, 1999.
    • Dubey AK, Cruz J, Hartog B and Gindoff PR. Integrin adhesions molecules expression during development of preimplantation human embryos. 55th Annual Meeting of ASRM, September 25-29th, Toronto, Canada, 1999.
    • Dubey AK, Nater, C, Sutherland, ML, Peak, D Hartog B, and Gindoff, PR. Apotosis in human: Expression of p53 in human preimplantation embryo. Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Department of Pharmacology; George Washington University Medical Center, Washington, DC USA, IVF World Congress 2001.
    • Stratton P, Hartog B, Hajizadeh JP, Sutherland D, Merino M, Lee JY, and Nieman LK. A single mid-Follicular dose of CDB – 2914, a new antiprogestin inhibits colliculogenesis and endometrial differentiation in normally cycling women. Human Reproduction. 15: 1092-1099.
    • Dubey A, Cruz J, Hartog B, Gindoff PR. Expression of the αV Integrin Adhesion Molecule during Development of Preimplantation Human Embryos. Fertility and Sterility. 76, July 2001.
    • Stratton P. Levens ED, Hartog B, Piquion J, Wei Q, Merino M, Nieman LK, Endometrial effects of a single early luteal dose of selective progesterone receptor modulator CDB-2914. Fertility and Sterility. Feb 2009

    Request a Free Appointment

    How would you prefer to be contacted?

    FREE initial consultation for all new patients. We also accept many health and medical insurance plans that cover this appointment.

    Please be aware that Chelsea Fertility NYC cannot accept new international patients over the telephone or internet; this information is intended for educational purposes only.